Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. - Wikidata - wikimedia - TriplyDB

Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review.

Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review.

http://www.wikidata.org/entity/Q37352112

about

Bisphosphonate therapy for osteogenesis imperfecta Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation Osteochemonecrosis: an overview WHOLE-BODY VIBRATION EXERCISE IMPROVES FUNCTIONAL PARAMETERS IN PATIENTS WITH OSTEOGENESIS IMPERFECTA: A SYSTEMATIC REVIEW WITH A SUITABLE APPROACH.Bisphosphonate treatment for children with disabling conditions.The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.Osteogenesis imperfecta: a case report and review of literature.Bisphosphonate therapy for osteogenesis imperfecta.Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model.Bisphosphonate Use and Risk of Implant Revision after Total Hip/Knee Arthroplasty: A Meta-Analysis of Observational Studies The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta.Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta.Bone mineral density in developing children with osteogenesis imperfecta: a longitudinal study with 9 years of follow-up.New perspectives on osteogenesis imperfecta Causes, mechanisms and management of paediatric osteoporosis.Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.An ENU-induced splice site mutation of mouse Col1a1 causing recessive osteogenesis imperfecta and revealing a novel splicing rescue Complications of pamidronate therapy in paediatric osteoporosis.Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats.Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats.Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model.Effects of Pamidronate on Dental Enamel Formation Assessed by Light Microscopy, Energy-Dispersive X-Ray Analysis, Scanning Electron Microscopy, and Microhardness Testing.Pamidronate "zebra lines": A treatment timeline.

P2860

Q24194821-C4D0FD41-FD40-4562-B15B-E3354A1F4D36 Q24610376-DB127378-18A6-41DE-BB8D-1EFD0C6594FC Q26827072-C250611D-FCB6-4DBB-BAA5-D14BBE452459 Q33624037-3BEB1031-F586-4655-8CE3-93DD10AC3696 Q33680621-7E7FFEF9-9F35-48EE-8360-D8176F494700 Q33781943-8D67F6CE-A2E4-4466-A743-08F15455A40E Q33852718-C3F3A041-C314-4D35-83F8-9E00CD5D9372 Q34543060-1FD7D295-A82E-4CEA-B910-3DB32E52BF3B Q35828143-AEE9EBC2-E125-4ECF-AA16-DC907846616A Q35913299-371086D6-1FB7-4C10-8642-A8ADFE8EE4C5 Q36132924-29E042AD-7624-4FA2-B05E-94ACFBF94863 Q36313702-0CE5EAB7-7E20-4F96-A16C-EDDFB6272B02 Q36662940-DAB03340-D94C-4E6F-9D5C-D6D6D92716BB Q37119320-1615166D-5906-45D1-A25C-3189DCFBDACE Q37158425-B10641B4-9BBA-496B-909D-3FB418DEEC45 Q37889113-1747ABD1-5DFB-4EE4-A4D5-482645BD4686 Q38099517-9A10C112-7850-471E-81C0-37A7A6870761 Q38617388-E221A712-0061-4064-A5AB-9806BBD39B4B Q41718522-610A598E-16A9-40E6-9A27-148F2A26B638 Q42583327-D1E44CEE-E419-4AEC-91BF-E0F71DD28338 Q46971365-727CD5E0-32F0-4309-A0DD-74AA57D1BE22 Q51781971-9409A0CC-C15B-4427-B010-C6C7776D2AB3 Q52653933-77B17BE6-9F52-4077-84B6-27994C41A6CE Q53096539-8D664BC4-5249-43FE-BC13-6975B0A00910 Q55064551-F8D77978-5E39-4487-B347-1F47367381DC

P2860

Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review.

http://www.wikidata.org/entity/Q37352112

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@en

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@nl

type

label

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@en

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@nl

prefLabel

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@en

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@nl

P1433

Q37352112-89D58EED-A73A-4324-9667-93D970A65398

P1476

Q37352112-0872FDD0-AAA0-40E6-9D1A-D309A605A2FD

P2093

Q37352112-46C0297A-7958-453F-8AC9-8444DE6E0F80

Q37352112-5F5DFA88-A368-4029-9639-09EF3329D712

Q37352112-70F8D027-1B41-41D4-9BB8-4C4F95130DAF

P2860

Q37352112-39E7EA4C-8FF2-4A61-A7ED-5DB6F33AA9BC

Q37352112-510BDD8F-3125-44E6-93C1-77B7B2E9F54D

Q37352112-8379A966-A80B-4E6C-898A-4ED86DE60368

Q37352112-84D72D8E-5724-4E37-94B1-A9110668A13B

Q37352112-A181AB74-8400-4FB0-A59D-4A8D90FD65CB

Q37352112-AA6F3081-F6DA-4875-B25F-228583C44067

Q37352112-E882F4F0-04C3-4BD0-9A5A-56ECF2F46AB3

Q37352112-F1C72633-DBA6-4151-84B8-B66FF3FFC2C6

P304

Q37352112-246C02D0-A47B-4147-9471-35DF1265042D

P31

Q37352112-DC8FBE1D-B378-4E04-9B72-B9698633CFD8

P356

Q37352112-85B8DDB3-2279-4F93-B4ED-1CFD10E74366

P433

Q37352112-437665EA-5DF2-41B7-9955-29F4C2673190

P478

Q37352112-B7FFFA99-0826-42FB-B7E9-9768F0891606

P577

Q37352112-80F81C93-5AC0-4818-A62D-B5C51439FC7A

P5875

Q37352112-3734A1D3-2F82-475B-9627-1A1D92751998

P698

Q37352112-49BEC8D9-5165-4381-BEEE-10082BE0F3D2

P921

Q37352112-3AAB84E2-733C-4F2D-8891-90FC28164784

P356

J.1469-8749.2008.03222.X

P1433

Developmental Medicine and Child Neurology

P1476

Effects of bisphosphonates in ...... : an AACPDM systematic review.

@en

P2093

American Academy for Cerebral ...... utcomes Committee Review Panel

http://www.w3.org/2001/XMLSchema#string

Heidi Castillo

http://www.w3.org/2001/XMLSchema#string

Lisa Samson-Fang

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.

Modeling the benefits of pamidronate in children with osteogenesis imperfecta.

Radiographic features of bisphosphonate therapy in pediatric patients.

Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.

Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta.

Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta.

A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta.

Surgery versus surgery plus pamidronate in the management of osteogenesis imperfecta patients: a comparative study.

P304

17-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1469-8749.2008.03222.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23668094

http://www.w3.org/2001/XMLSchema#string

P698

19087101

http://www.w3.org/2001/XMLSchema#string

P921

osteogenesis imperfecta